Skip to main content
  • World Health Organization Global
  • Regions
    World Health Organization WHO Regional websites
    • Africa Africa
    • Americas Americas
    • South-East Asia South-East Asia
    • Europe Europe
    • Eastern Mediterranean Eastern Mediterranean
    • Western Pacific Western Pacific
When autocomplete results are available use up and down arrows to review and enter to select.
Home
      • Home
      • Health Topics
      • All topics
      • A
      • B
      • C
      • D
      • E
      • F
      • G
      • H
      • I
      • J
      • K
      • L
      • M
      • N
      • O
      • P
      • Q
      • R
      • S
      • T
      • U
      • V
      • W
      • X
      • Y
      • Z
      • Resources
        • Fact sheets
        • Facts in pictures
        • Multimedia
        • Podcasts
        • Publications
        • Questions and answers
        • Tools and toolkits
      • Popular
        • Dengue
        • Endometriosis
        • Excessive heat
        • Herpes
        • Mental disorders
        • Mpox
      • Countries
      • All countries
      • A
      • B
      • C
      • D
      • E
      • F
      • G
      • H
      • I
      • J
      • K
      • L
      • M
      • N
      • O
      • P
      • Q
      • R
      • S
      • T
      • U
      • V
      • W
      • X
      • Y
      • Z
      • Regions
        • Africa
        • Americas
        • Europe
        • Eastern Mediterranean
        • South-East Asia
        • Western Pacific
      • WHO in countries
        • Data by country
        • Country presence 
        • Country cooperation strategies 
        • Country office profiles
        • Strengthening country offices 
      • Newsroom
      • All news
        • News releases
        • Statements
        • Campaigns
        • Events
        • Feature stories
        • Press conferences
        • Speeches
        • Commentaries
        • Photo library
      • Headlines
      • Emergencies
      • Focus on
        • Cholera 
        • Coronavirus disease (COVID-19)
        • Greater Horn of Africa
        • Israel and occupied Palestinian territory
        • Mpox
        • Sudan
        • Ukraine
      • Latest
        • Disease Outbreak News
        • Situation reports
        • Rapid risk assessments
        • Weekly Epidemiological Record
      • WHO in emergencies
        • Surveillance
        • Alert and response
        • Operations
        • Research
        • Funding
        • Partners
        • Health emergency appeals
        • International Health Regulations
        • Independent Oversight and Advisory Committee
      • Data
      • Data at WHO
        • Data hub
        • Global Health Estimates
        • Mortality
        • Health inequality
      • Dashboards
        • Triple Billion Progress
        • Health Inequality Monitor
        • Delivery for impact
        • COVID-19 dashboard
      • Data collection
        • Classifications
        • SCORE
        • Surveys
        • Civil registration and vital statistics
        • Routine health information systems
        • Harmonized health facility assessment
        • GIS centre for health
      • Reports
        • World Health Statistics
        • UHC global monitoring report
      • About WHO
      • About WHO
        • Partnerships
        • Committees and advisory groups
        • Collaborating centres
        • Technical teams
        • Organizational structure
        • Who we are
      • Our work
        • Activities
        • Initiatives
        • General Programme of Work
        • WHO Academy
      • Funding
        • Investment in WHO
        • WHO Foundation
      • Accountability
        • External audit
        • Financial statements
        • Internal audit and investigations 
        • Programme Budget
        • Results reports
      • Governance
        • Governing bodies
        • World Health Assembly
        • Executive Board
        • Member States Portal

      F.3 Rifapentine – 150 mg dispersible tablet

      Application, expert reviews and public comments

      Application

      F.3 Rifapentine – 150 mg dispersible tablet
      F.3 Rifapentine – 150 mg dispersible tablet - pQTPP

       

      Expert reviews

      Expert Review 1

      Expert Review 2

      Comments

      Sentinel Project on Pediatric Drug-Resistant TB

      TB Europe Coalition

      Médecins Sans Frontières

      • Regions
        • Africa
        • Americas
        • Eastern Mediterranean
        • Europe
        • South-East Asia
        • Western Pacific
      • Policies
        • Cybersecurity
        • Ethics
        • Information disclosure
        • Permissions and licensing
        • Preventing sexual exploitation
        • Terms of use
      • About us
        • Careers
        • Frequently asked questions
        • Library
        • Procurement
        • Publications
      • Contact us
      Newsletters
      Report misconduct
      Home
      Privacy policy
      © 2025
      WHO